Iyar Mazar
Iyar Mazar publishes mostly in Economics and Econometrics, Oncology and Molecular Biology, on topics such as Mitochondrial Function and Pathology, Health Systems, Economic Evaluations, Quality of Life and Cancer survivorship and care.
- World rank
- #5,037,335 of 7,710,434 ranked researchers
- Rank in United States
- #1,304,714 of 1,627,098
- Works
- 37
- Citations
- 476
- Citations per work
- 12.9
What does Iyar Mazar research?
Iyar Mazar's work is mostly in Medicine (20%), Economics, Econometrics and Finance (11%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2156.9%
- Health Sciences924.5%
- Medicine719.6%
- Health Professions24.9%
- Social Sciences410.8%
- Life Sciences37.8%
- 1Economics and Econometrics11% of their works
- 2Oncology8% of their works
- 3Molecular Biology8% of their works
- 4Rheumatology7% of their works
- 5Neurology5% of their works
- 6General Health Professions5% of their works
Research topics
- Mitochondrial Function and Pathology
- Health Systems, Economic Evaluations, Quality of Life
- Cancer survivorship and care
- Economic and Financial Impacts of Cancer
- Statistical Methods in Clinical Trials
- Adolescent and Pediatric Healthcare
- Cancer Treatment and Pharmacology
- Childhood Cancer Survivors' Quality of Life
Which keywords describe Iyar Mazar's research?
The keywords of their largest research topics: Quality of Life, Health-related Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Mitochondria, Reactive Oxygen Species, Cancer Survivorship and Patient-Reported Outcomes.
- Transition
- Pediatric Quality of Life Inventory
- Childhood Cancer Survivor Study
- Adolescents
- Financial Toxicity
- Patient-Reported Outcomes
- Reactive Oxygen Species
- Health Utility Measures
- Health-related Quality of Life
- Quality of Life
- Cost-effectiveness Analysis
- Mitochondria
- Cancer Survivorship
- Cost of Care
- Adaptive Designs
- Chemotherapy-Induced Peripheral Neuropathy
- False Discovery Rate
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Quality of Life143 topics
- Health-related Quality of Life82 topics
- Cost-effectiveness Analysis61 topic
- Health Utility Measures61 topic
- Mitochondria61 topic
- Reactive Oxygen Species61 topic
- Cancer Survivorship51 topic
- Patient-Reported Outcomes51 topic
- Cost of Care41 topic
- Financial Toxicity41 topic
- Adaptive Designs31 topic
- Adolescents31 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Childhood Cancer Survivor Study31 topic
- False Discovery Rate31 topic
- Pediatric Quality of Life Inventory31 topic
- Taxanes31 topic
- Transition31 topic
Where does Iyar Mazar work?
Iyar Mazar's main affiliation in the publication record is Adelphi Laboratory Center, United States.
How many publications and citations does Iyar Mazar have?
OpenAlex counts 37 works and 476 citations for Iyar Mazar, an h-index of 10, ranking #5,037,335 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Iyar Mazar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.